A Clinical Trial of Thread-embedding Therapy at Acupuncture Point for Simple Obesity
A Clinical Trial of Acupoint Thread-embedding Therapy for Simple Obesity
1 other identifier
interventional
100
1 country
1
Brief Summary
Thread-embedding Therapy has been used for treating Obesity in recent years. This research is aimed to observe the clinical effect of thread-embedding therapy in treating Simple Obesity. One hundred patients is planned to be enrolled in the research and receive a thread-embedding therapy. The level of BMI, serum triglyceride, cholesterol and fasting blood glucose will be adopted for evaluation before and after therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2017
CompletedFirst Submitted
Initial submission to the registry
September 3, 2017
CompletedFirst Posted
Study publicly available on registry
October 30, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2018
CompletedOctober 30, 2017
June 1, 2017
12 months
September 3, 2017
October 26, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The change Body Weight
a 5 percent of loss of body weight will be judged as effective
participants will receive Thread-embedding Therapy twice a week lasting for 16 weeks subsequently.8 times in all.
Secondary Outcomes (3)
The effection on cholesterol
Therapy is the same as mentioned above. Participants will take blood test at the beginning of the first week of the therapy, and at the end of the 16th week.
The effection on triglyceride
Therapy is the same as mentioned above. Participants will take blood test at the beginning of the first week of the therapy, and at the end of the 16th week.
The effection on fasting blood glucose
Therapy is the same as mentioned above. Participants will take blood test at the beginning of the first week of the therapy, and at the end of the 16th week.
Study Arms (1)
participants received treatment
EXPERIMENTAL100 participants who are diagnosed as simple obesity under the standards of... are planned to enrolled in the trial. Each will receive Thread-embedding therapy.
Interventions
Eligibility Criteria
You may qualify if:
- patients with age from 18 to 60 years old;
- patients with BMI≥ 24, meanwhile waist more than 85 cm (for male) or 80 cm (for female);
- patients with diagnosed as central adiposity and/or Simple obesity according to the diagnosis criteria;
- patients who is willing to cooperate with the test treatment and signed informed consent.
You may not qualify if:
- Pregnant or lactating women;
- patients who Syncope after acupuncture;
- patients who present hypersensitivity reactions after acupoint-embedding therapy;
- patients with serious heart, liver, kidney, brain and other diseases;
- patients with severe primary diseases;
- patients with psychiatric diseases;
- participants who did not complete dietary control and physical exercise as the protocol described.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Digestive Diseases of Longhua Hospital affiliate to Shanghai University of Traditional Chinese Medicine
Shanghai, Shanghai Municipality, 200032, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 3, 2017
First Posted
October 30, 2017
Study Start
January 3, 2017
Primary Completion
December 31, 2017
Study Completion
March 31, 2018
Last Updated
October 30, 2017
Record last verified: 2017-06